Zubik v. Burwell highlights thorny issues surrounding Obamacare’s contraceptive coverage requirement.
Regulatory capture, neither inevitable nor a death trap for agencies, must be reduced to advance public policy goals.
Reviving our regulatory system should be a top priority for the next President.
FDA issues new guidelines to medical device manufacturers to mitigate cybersecurity concerns.
Agenda details some of the Administration's high priority rules for 2016.
The FDA requests information in possible first steps to regulate the term “natural” on food labels.
Researchers argue for reducing FDA involvement in medical device regulation.
Scholar argues that new food safety regime sacrifices environmental well-being.
New agency rule focuses on preventing risks to food meant for human consumption.
The FDA has proposed adding to product labels daily percentages for added sugars.